Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD.
Bram VerstocktSare VerstocktJonathan CremerJoão SabinoMarc FerranteSeverine VermeirePadhmanand SudhakarPublished in: BMJ open gastroenterology (2023)
Transcriptomic profiling of circulating CD4 T-cells in patients with IBD demonstrated marked molecular differences between the IBD-spectrum extremities (UC and predominantly ileal CD, sandwiching colonic CD), which could help in prioritising particular drug targets for IBD subtypes.